Laboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.
Academia BAI, Luanda, Angola.
Clin Respir J. 2023 May;17(5):439-446. doi: 10.1111/crj.13612. Epub 2023 Apr 27.
Pseudomonas aeruginosa respiratory infections are challenging, and the risk of recurrence is a frequent problem. The aim of this study was to investigate the risk factors associated with the presence of P. aeruginosa, and the risk factors related to the recurrence and death of lower airway infections in inpatients in a Brazilian hospital.
Retrospective cohort with inpatients that had a sample of airways culture (tracheal aspirate or bronchoalveolar lavage) with the detection of P. aeruginosa. The patients with clinical criteria of infection were classified as ventilator-associated, hospital-acquired, or community-acquired pneumonia. P. aeruginosa in respiratory samples without symptoms was considered colonization. The antimicrobial treatment adequacy and the clinical data were evaluated. Outcome variables included mortality and recurrence.
One hundred and fifty-four patients were included in the study, most of them were men, and the majority (102) were considered infected. The average length of stay was superior to 30 days. Previous pulmonary disease was associated with the occurrence of colonization. Aminoglycosides were the most active drug according to susceptibility tests and were successfully used as monotherapy. Septic shock was a risk factor for death in the infected patients. The use of adequate antimicrobial therapy was associated with major survival, independent of the infection classification.
It is possible to evaluate clinical data associated with recurrence and mortality in patients with different lung infections by P. aeruginosa. Aminoglycoside monotherapy is safe and effective in P. aeruginosa respiratory infections.
铜绿假单胞菌呼吸道感染具有挑战性,且复发风险是一个常见问题。本研究旨在调查与巴西医院住院患者下呼吸道感染中铜绿假单胞菌存在相关的风险因素,以及与复发和死亡相关的风险因素。
回顾性队列研究纳入了进行呼吸道样本(气管抽吸物或支气管肺泡灌洗)培养且检出铜绿假单胞菌的住院患者。具有感染临床标准的患者被分类为呼吸机相关性肺炎、医院获得性肺炎或社区获得性肺炎。无症状的呼吸道样本中的铜绿假单胞菌被认为是定植菌。评估了抗菌治疗的充分性和临床数据。结局变量包括死亡率和复发率。
本研究纳入了 154 名患者,大多数为男性,其中 102 名被认为感染。平均住院时间超过 30 天。既往肺部疾病与定植有关。根据药敏试验,氨基糖苷类药物是最有效的药物,且成功地作为单药治疗使用。感染患者发生感染性休克是死亡的危险因素。使用适当的抗菌治疗与生存率显著相关,与感染分类无关。
可以评估不同肺部感染患者的临床数据与复发和死亡率的相关性。铜绿假单胞菌呼吸道感染时,氨基糖苷类药物单药治疗安全且有效。